Managers / Q1 2020 · view latest →
Context Capital Management, LLC
CIK 0001301396 · 7724 GIRARD AVENUE - 3RD FLOOR, SUITE 300, LAJOLLA, CA, 92037 · 8584813666
Reported Value
$176M
Q1 2020
Positions
102
Filings on Record
32
2019–present window
Filed
May 12, 2020
original filing
Summary
Context Capital Management, Llc reported $176M in U.S.-listed holdings across 102 positions for Q1 2020.
Its largest position, Inovio Pharmaceuticals, represents 6.3% of the portfolio.
Compared with Q4 2019, the fund opened 28 new positions and exited 27.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
Composition data arrives with ticker enrichment.
Quarter-over-Quarter Changes full breakdown →
Holdings — Q1 2020
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $4.3B | 392 | May 7, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $3.9B | 327 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $3.2B | 269 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $3.0B | 251 | Aug 6, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $2.6B | 208 | May 5, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $2.6B | 238 | Feb 11, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $3.7B | 284 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $2.8B | 222 | Aug 9, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $2.1B | 277 | May 2, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $1.5B | 281 | Feb 16, 2024 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2023 | $1M | 311 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $1M | 315 | Aug 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $1M | 346 | May 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $1.4B | 477 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $1.5B | 594 | Nov 7, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $1.4B | 619 | Aug 3, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $1.5B | 688 | May 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $1.3B | 554 | Feb 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $979M | 473 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $1.1B | 526 | Aug 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $1.0B | 462 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $731M | 261 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $460M | 165 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $257M | 105 | Aug 11, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $176M | 102 | May 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $200M | 101 | Feb 7, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $176M | 91 | Nov 1, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $172M | 92 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $164M | 86 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $177M | 80 | Feb 13, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.